NDC 71432-2002-01 - tacrolimus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71432-2002
- Requested NDC
- 71432-2002-01
- Package NDCs from labels
- 71432-2002-1, 71432-2002-01
- Manufacturer
- Chengdu Suncadia Medicine Co., Ltd.
- Effective date
- 2024-02-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| tacrolimus extended-release capsules - Chengdu Suncadia Medicine Co., Ltd. | Chengdu Suncadia Medicine Co., Ltd. | 2024-02-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71432-2002-1 | tacrolimus | 5 in 1 BAG | CAPSULE, COATED, EXTENDED RELEAS | 5 | 5 | |
| 71432-2002-1 | tacrolimus | 1 in 1 CARTON | CAPSULE, COATED, EXTENDED RELEAS | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71432-2002 | TACROLIMUS (TACROLIMUS EXTENDED-RELEASE CAPSULES) CAPSULE, COATED, EXTENDED RELEASE [CHENGDU SUNCADIA MEDICINE CO., LTD.] | 5 | Current NDC, 2 package rows | 20240213_08cf2861-2483-405d-a872-a88a5c235f9a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tacrolimus | TACROLIMUS | Proficient Rx LP | 20d1c12a-bf4b-4467-93a0-ee8b892abea9 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Biocon Pharma Inc. | 0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f | 2023-09-28 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Prograf | TACROLIMUS | Astellas Pharma US, Inc. | 7f667de1-9dfa-4bd6-8ba0-15ee2d78873b | 2023-08-25 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Padagis Israel Pharmaceuticals Ltd | 6b601eaf-4f3a-4a8b-8cd8-1000defa9822 | 2021-11-15 | Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Aphena Pharma Solutions - Tennessee, LLC | 4caa20af-45a8-4365-9f06-1568afae61b1 | 2017-05-03 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.